EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors-Reference-Cited by-同舟云学术

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

Published:2015-01-28 Issue:7546 Volume:520 Page:239-242
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Fillmore Christine M.,Xu Chunxiao,Desai Pooja T.,Berry Joanne M.,Rowbotham Samuel P.,Lin Yi-Jang,Zhang Haikuo,Marquez Victor E.,Hammerman Peter S.,Wong Kwok-Kin,Kim Carla F.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14122.pdf

Reference51 articles.

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011)

2. Zornosa, C. et al. First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions. J. Natl. Compr. Canc. Netw. 10, 847–856 (2012)

3. Wang, L. et al. Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer. Lung Cancer 77, 89–96 (2012)

4. Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome – biological and translational implications. Nature Rev. Cancer 11, 726–734 (2011)

5. Simon, J. A. & Lange, C. A. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 647, 21–29 (2008)

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis;Modern Pathology;2024-11

2. Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma;British Journal of Cancer;2024-03-22

3. DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models;Journal of Clinical Investigation;2024-03-07

4. A rare Ewing-like small round cell tumor in prostate: a case report and literature review;Journal of Cancer Research and Clinical Oncology;2024-03-01

5. The innovative checkpoint inhibitors of lung adenocarcinoma, cg09897064 methylation and ZBP1 expression reduction, have implications for macrophage polarization and tumor growth in lung cancer;Journal of Translational Medicine;2024-02-18